Compare FedEx Corporation (FDX) vs Tenet Healthcare Corporation (THC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
FedEx Corporation vs Tenet Healthcare Corporation — how do they compare? FedEx Corporation trades at $292 (market cap $68.41B), while Tenet Healthcare Corporation trades at $260 (market cap $20.92B). The key difference: FedEx Corporation is far larger — about 3.3× Tenet Healthcare Corporation's market cap, and FedEx Corporation pays a 1.69% dividend while Tenet Healthcare Corporation pays none. Which is the better fit depends on your goals — on Pluang, investors hold FedEx Corporation for 87 Days and Tenet Healthcare Corporation for 15 Days on average.
| FDX | THC | |
|---|---|---|
Market Cap | $68.41B | $20.92B |
Volume | 1,232,551 | 455,764 |
Sector | Industrials | Health |
52-Week High | $339.35 | $280.77 |
52-Week Low | $180.87 | $161.37 |
Typical Hold Time | 87 Days | 15 Days |
Enterprise Value | $98.04B | $32.00B |
Dividend Yield | 1.69% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FedEx (FDX) trades at $291.73, up 0.93% today, with a bearish technical signal from moving averages and oscillators. The company shows solid fundamentals with a P/E of 15.58 and net income margin of 4.68%, though revenue has been flat near $88B. Recent news includes a $300M electric truck order and shareholder approval of executive pay, while earnings have beaten estimates in recent quarters.
The outlook is mixed: analyst consensus is bullish with a $307.55 price target, but rising fuel costs and net cash outflows pose risks. Investment appeal lies in cost-cutting efforts and industry recovery, balanced against macroeconomic pressures and competitive threats in logistics.
Tenet Healthcare (THC) trades at $259.83, up 0.53% with strong technical momentum and bullish moving average signals. The company demonstrates robust fundamentals with consistent earnings beats (Q4 2025-Q2 2026), 82.83% gross margins, and 53.31% ROE. Recent news highlights strong cash flow supporting capital returns, with Q3 2026 results expected October 29, 2026.
THC presents compelling value with a 10.04 P/E ratio and 81.25% analyst buy ratings. Upside potential to $283.36 consensus target exists, though negative cash flow trends and insider selling warrant monitoring. The stock's premium valuation (P/B 4.49) requires sustained execution amid healthcare sector volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About FedEx Corporation
FedEx pioneered overnight delivery in 1973 and remains the world's largest express package provider. In its fiscal 2020 (ended May 2020), FedEx derived 51% of revenue from its express division, 33% from ground, and 10% from freight, its asset-based less-than-truckload shipping segment. The remainder comes from other services, including FedEx Office, which provides document production/shipping, and FedEx Logistics, which provides global forwarding. FedEx acquired Dutch parcel delivery firm TNT Express in 2016. TNT was previously the fourth-largest global parcel delivery provider.
Read more on FDX →About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →
